Skip to content

Avanos Medical AVNS Impairment Charges

Impairment Charges at other companies

Baxter International logo
Baxter InternationalBAX
$0-100%
Scansource logo
ScansourceSCSC
$0
Charles River Laboratories logo
Charles River LaboratoriesCRL
$15.86M+50.0%
Henry Schein logo
Henry ScheinHSIC
$0-100%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill.

The official record: Avanos Medical’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's impairment charges?
Avanos Medical (AVNS) reported impairment charges of $0 in Q4 2025.
What is the long-term trend for Avanos Medical's impairment charges?
Over 2 years (2021 to 2025), Avanos Medical's impairment charges has grown at a -100.0% compound annual growth rate (CAGR), from $7.9M to $0.
What does impairment charges mean?
Write-downs of long-lived assets (excluding goodwill) when their carrying value exceeds fair value, including property, equipment, right-of-use assets, and other tangible assets.